Laser Speckle Imaging for Wound Perfusion Monitoring (WoundImager)

NCT ID: NCT01675583

Last Updated: 2013-07-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the efficacy of an optical device designed and developed to quantitatively monitor blood flow velocity of wound sites. It is hypothesized that the blood flow velocity of the wound site will provide critical information on the efficacy of hyperbaric oxygen therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wounds and Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care Group

Subjects who will undergo only standard wound care management.

No interventions assigned to this group

Hyperbaric Oxygen Therapy Group

Subjects who are selected for adjunctive hyperbaric oxygen therapy in addition to standard wound care intervention.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects age 21 or older with the following types of wounds and who are able to comply with the study requirements:

* Necrotizing fasciitis
* Compromised/failed skin grafts/flaps
* Chronic refractory osteomyelitis
* Soft tissue radiation necrosis
* Diabetic wounds, lower extremity
* Acute peripheral arterial insufficiency
* Crush injury
* Venous leg disease
* Pressure ulcer
* Other chronic, non-healing wounds
* Subjects must have signed the Informed Consent Forms.

Exclusion Criteria

* Female subjects who are pregnant or nursing.
* Anyone who is unable to give written informed consent
* Subjects with end-stage renal disease or who require peritoneal or hemodialysis.
* Subjects with current malignancies.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

CW Optics, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Winchester Medical Center

Winchester, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R44HL059807-06

Identifier Type: NIH

Identifier Source: secondary_id

View Link

WoundImager-2012-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Skin Imaging With Technologies in Development
NCT00764920 ACTIVE_NOT_RECRUITING